Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Share Capital (Tables)

v3.20.2
Share Capital (Tables)
 6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Schedule of shares issued granted options
  Six months ended June 30, 2020
    Number of options granted     Exercise
price
range		     Vesting
period		   Expiration
Employees     317,909     $ 10.08     4 years   10 years
Directors     162,713     $ 11.06     4 years   10 years

 

    Six months ended June 30, 2019
    Number of options granted     Exercise
price
range		     Vesting
period
range		   Expiration
Employees     230,000     $ 5.07     4 years   7 years
Directors     286,390     $ 5.07     4 years   7 years
Consultants     5,000       5.07     4 years   7 years
Schedule of fair value options granted
    Six months ended
June 30		  
    2020     2019  
Value of ordinary share   $ 9.99-$10.5     $ 5.7-$5.9  
Dividend yield     0 %     0 %
Expected volatility     66.05%-66.41 %     61.31%-61.71 %
Risk-free interest rate     0.29%-0.35 %     1.87%-2.49 %
Expected term     6.11 years       4 years  
Schedule of share-based compensation
    Three months ended
June 30		     Six months ended
June 30		  
    2020     2019     2020     2019  
    U.S. dollars in thousands     U.S. dollars in thousands  
Research and development expenses, net   $ 152     $ 108     $ 237     $ 215  
General and administrative expenses     325       181       557       414  
    $ 477     $ 289     $ 794     $ 629